Scarica l'app Stockscreener
77.78
1.21%
0.93
Dopo l'orario di chiusura:
78.10
0.32
+0.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$76.85
Aprire:
$78.02
Volume 24 ore:
470.25K
Relative Volume:
0.69
Capitalizzazione di mercato:
$2.28B
Reddito:
$267.23M
Utile/perdita netta:
$-83.50M
Rapporto P/E:
-25.01
EPS:
-3.11
Flusso di cassa netto:
$-59.99M
1 W Prestazione:
-11.72%
1M Prestazione:
-13.72%
6M Prestazione:
-37.25%
1 anno Prestazione:
-12.92%
Intervallo 1D:
$75.70
$80.00
Intervallo di 1 settimana:
$75.52
$95.38
Portata 52W:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
888-729-1206
Indirizzo
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
77.78 | 2.28B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-05-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Mostra tutto
Genedx Holdings Corp Borsa (WGS) Ultime notizie
New Highs: What makes GeneDx Holdings Corp stock attractive today2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500
Aug Drivers: Does GeneDx Holdings Corp Equity Warrant stock benefit from AI growth2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx stock falls as Natera launches competing rare disease test - Investing.com India
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note? - Benzinga
Discipline and Rules-Based Execution in WGS Response - Stock Traders Daily
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons - Investing.com South Africa
AI Stocks: What is the Moat Score of GeneDx Holdings Corp2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
$80,000 per child: gene tests shift kids from ER to planned care - Stock Titan
Why Is Zevra Therapeutics Stock Trading Higher Today? - Bitget
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force - MSN
Genedx Earnings Call Signals Strong Genomics Growth - The Globe and Mail
GeneDx (NASDAQ:WGS) Trading Down 5.6%Time to Sell? - MarketBeat
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
GeneDx Holdings Corp. to Launch Genetic Testing Program with Zevra Therapeutics, Inc. to Support Patients with Suspected Niemann-Pick Disease Type C - marketscreener.com
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C - Yahoo Finance
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments - Yahoo Finance
Aug Drivers: What are the risks of holding GeneDx Holdings Corp2026 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
GeneDx CFO Feeley sells $486k in shares - Investing.com Nigeria
Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to Trade - Finviz
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership - Business Wire
GeneDx (WGS) CFO Kevin Feeley acquires 1,986 shares from issuer - Stock Titan
Keith Meister Buys Shares Of GeneDx – Insider Weekends (NASDAQ:WGS) - Seeking Alpha
Setup Watch: Is GeneDx Holdings Corp Equity Warrant a stock for growth or value investors2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Aug Mood: What are the risks of holding GeneDx Holdings Corp2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
GeneDx Holdings Inc. Stock Rises Amid Strong Q4 Results and Market Expansions - timothysykes.com
Setup Watch: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stockQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading Action: Can GeneDx Holdings Corp Equity Warrant continue delivering strong returns2025 Stock Rankings & Long Hold Capital Preservation Tips - baoquankhu1.vn
Energy Moves: Can GeneDx Holdings Corp deliver alphaJobs Report & Free Long-Term Investment Growth Plans - baoquankhu1.vn
GeneDx Achieves Strong Q4 Growth Amid Positive Outlook for 2026 - StocksToTrade
GeneDx Stock Climbs After Strong Q4 Results and Bullish 2026 Guidance - timothysykes.com
GeneDx Rides Fiscal Gains with Bright 2026 Forecast - StocksToTrade
GeneDx (WGS) Outperforms With Strong Quarter Results, Positive Earnings Outlook Draws Focus - timothysykes.com
GeneDx Stock Soars Following Strong Q4 Results and Updated 2026 Guidance - StocksToTrade
Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Steven A. Cohen, Warren Buffett, Scott Bessent, Sabal Capital Management, Point72 Asset Management, GeneDx Holdings Corp (WGS), DXP Enterprises Inc (DXPE), and More - Insider Monkey
Market Review: Is GeneDx Holdings Corp Equity Warrant showing insider buyingSwing Trade & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Keith Meister Purchases 140,026 Shares of GeneDx (NASDAQ:WGS) Stock - MarketBeat
Insider Buying: GeneDx (NASDAQ:WGS) Director Buys 29,495 Shares of Stock - MarketBeat
GeneDx CFO Feeley sells $486k in shares By Investing.com - Investing.com UK
Corvex management buys GeneDx (WGS) shares worth $13.4 million By Investing.com - Investing.com India
Corvex management buys GeneDx (WGS) shares worth $13.4 million - Investing.com
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 25,459 Shares - MarketBeat
GeneDx (NASDAQ:WGS) CFO Sells $486,360.07 in Stock - MarketBeat
Genedx Holdings Insider Sold Shares Worth $486,370, According to a Recent SEC Filing - marketscreener.com
GeneDx (WGS) CEO reports RSU grant and tax-related share sales - Stock Titan
Free cash flow per share of GeneDx Holdings Corp. Class A – BX:WGS - TradingView
ARK Investment Management LLC Purchases New Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):